DATE
On Demand
TIME
On Demand
DURATION
On Demand
Drug diversion occurs any time a prescription medication is removed from its intended path from manufacturer to patient. With access to in-house pharmacies, hospitals and other medical centers experience drug diversion frequently. In fact, 10-15% of healthcare workers will misuse drugs at least once throughout their careers. To avoid the dangerous consequences of drug diversion, building an effective drug diversion program must be a priority for healthcare facilities worldwide.
Join Lucy Cannizzaro, Associate Director of Administration & Director of Pharmacy, Director of Regulatory Affairs at Mount Sinai Brooklyn; Bruce Sackman, Senior Investigator, Mount Sinai Health System; Raymond Shelton, HIPAA Security Officer at Mount Sinai Health System; Kara Earle, Senior Drug Diversion Specialist at FairWarning; and Tyler Carlson, Director, Sales Engineering & Pre-Sales at FairWarning for FairWarning’s Executive Series Webinar “Drug Diversion: Prevention, Detection, & Remediation.”
Learn More About:
- The effects of drug diversion in healthcare facilities
- Steps Pharmacy Directors can take towards prevention
- Building an effective drug diversion monitoring program
- How Mount Sinai Health System detects and mitigates drug diversion
Event Speakers:
- Lucy Cannizzaro, Associate Director of Administration & Director of Pharmacy, Director of Regulatory Affairs, Mount Sinai Brooklyn
- Bruce Sackman, Senior Investigator, Mount Sinai Health System
- Raymond Shelton, HIPAA Security Officer, Mount Sinai Health System
- Kara Earle, Senior Drug Diversion Specialist, FairWarning
- Tyler Carlson, Director, Sales Engineering & Pre-Sales, FairWarning